We came across a bearish thesis on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on ValueInvestorsClub by quads1025. In this ...

Walgreens Boots Alliance recognized a $12.4 billion impairment charge associated with the assets, I think the probability of getting anything from these rights is quite limited. This is not to say ...

Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The firm has a market cap of $9.29 billion, a P/E ratio of -1.05, a P/E/G ratio of 1.31 and a beta of 0.62.

We came across a bearish thesis on Walgreens Boots Alliance, Inc. (NASDAQ ... drugs and the potential for growth in this segment is limited. With branded drugs being costlier, Pharmacy Benefits ...

Shares of Walgreens Boots Alliance (NASDAQ ... Meanwhile, it appears upside is limited to about $0.30 at this point.

Bloomberg reported that a buyout of Walgreens by Sycamore Partners is ... Meanwhile, it appears upside is limited to about $0.30 at this point. Billy Duberstein and/or his clients have no position ...

Walgreens agreed to pay about $2.8 million to the federal government and the states of Massachusetts and Georgia to settle allegations that the company inflated prices for generic medications covered ...

Walgreens Boots Alliance (Nasdaq: WBA ... Such statements include, but are not limited to, statements regarding the proposed transaction, our ability to consummate the proposed transaction ...

Walgreens Boots Alliance, which owns the Boots pharmacy chain, has struck a deal worth up to $23.7 billion (€21.8 billion) with private equity group Sycamore Partners that will bring the ...

Walgreen Co. has agreed to pay over $2.8M to resolve allegations that it violated the federal, Massachusetts and Georgia False Claims Acts by ...